T Cell Processing and Cryopreservation Webinar Overview
With T cell therapies, such as CAR-T, rapidly emerging as a powerful new treatment and potential cure for cancer, understanding the optimal conditions to cryopreserve T cells is an important step towards developing better processes and better therapies.
In this webinar, you’ll learn strategies for cryopreserving leukapheresis material for T cell processing and how to extend leukopak stability for added flexibility in manufacturing T cell therapies. Watch now to learn:
- Why drug substance and drug product cryopreservation is important for successful CAR-T therapies
- Better strategies for cryopreserving leukapheresis material for T cell processing
- How to extend leukopak stability for processing in T cell therapies
- Striking the right balance in drug product formulation for excipients and cryoprotectants
- How drug product formulation can affect cell phenotype and function
About the Presenters
